Meet BrosMed at ESC Congress 2024
Release time:
2024-08-15
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
We can’t wait to engage with the masters and partners there, as well as showcase our professional toolkit for complex PCI toolkits, including:
Pronavi™ Microcatheter: Two low-profile options: 1.7F &1.9F, 135cm length for antegrade, 150cm & 162cm length for retrograde
Alveo™ HP CTO Balloon Dilatation Catheter: Smallest ø 0.75mm CTO Balloon in the world
Wedge™ NC Scoring PTCA Balloon Dilatation Catheter: Safe and controlled lesion preparation
POT™ PTCA NC Balloon Dilatation Catheter: Dedicated Balloon for POT and DOT Technique
Let’s meet at BrosMed Medical Booth #F205. If you will participate in this fantastic event, please contact us via email: sales@brosmed.com. Looking forward to seeing you there!
About BrosMed Medical
Specializing in the research, development, manufacturing, and global sales of interventional technologies and products for complex vascular diseases, BrosMed is the industry-leading multinational group in the field of intravascular interventional medical devices. We have over 20 product series and more than 400 product registration certificates worldwide. Our products cover various fields including cardiovascular intervention, peripheral intervention, vascular access, neurovascular intervention, and interventional accessories, and are marketed in over 90 countries and regions globally.
BrosMed Medical adheres to the mission of “Technology Embraces Life,” actively practices a globalized integration of medical and engineering, and promotes an open innovation model of integrating industry, universities, and scientific research institutions. We are dedicated to continuously providing safe, effective, high-quality, and innovative intravascular interventional solutions for global experts and patients.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
Webinar Invitation | Innovations and Novel Strategies in CHIP PCI
Mark your calendar: Wednesday, March 26 🕒 18:00-19:30 (Beijing Time) | 11:00-12:30 (CET)
2025-03-19
On February 10, BrosMed and Cordis signed an agreement for the exclusive distribution of VaSecure™, BrosMed’s next-generation drug-coated peripheral balloon catheter in the China market.
2025-02-12
BrosMed Medical Obtains CE Mark for RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical is excited to announce that it has obtained CE mark for the RevoEdge High-Pressure Coronary Cutting Balloon under the European Medical Device Regulation (MDR). Redefining the standards of cutting balloons, this cutting-edge device is designed to offer unparalleled cutting performance and crossability.
2025-01-07
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26